Medicine & Health

A study from Washington University School of Medicine suggests a strategy for preventing a chronic, slow-growing type of blood cancer from progressing to an aggressive form of leukemia.

A new grant from the Centers for Disease Control and Prevention (CDC) will support research at the School of Medicine to investigate the real-world effectiveness of COVID-19 and influenza vaccines.

The School of Medicine and pharmaceutical company Eisai Co. Ltd. have formed a research collaboration aimed at developing new treatments for Alzheimer’s disease and other neurodegenerative conditions.

Fangqiong Ling at the McKelvey School of Engineering and Likai Chen in Arts & Sciences developed a machine learning model that uses the assortment of microbes found in wastewater to tease out how many individual people they represent. Their study was published in PLOS Computational Biology.

Abhinav Jha, at the McKelvey School of Engineering, wants to use novel imaging to better understand how people absorb radiation therapy. His team won a four-year $2.2 million National Institutes of Health (NIH) grant for the study, which aims to guide treatment decisions.

A large study conducted in part by School of Medicine researchers focused on whether exercise and mindfulness training could boost cognitive function in older adults. The study found no such improvement following the interventions.

Proscovia Nabunya, at the Brown School; and Patricia Cavazos-Rehg, at the School of Medicine, have received a five-year $1.2 million research grant from the National Institute of Mental Health, part of the National Institutes of Health (NIH), to address depression among youth living with HIV in Uganda.

Patients with social needs had a higher number of hospitalizations, obesity, prediabetes and Type 2 diabetes, finds a new study from the Brown School on the social determinants of health.

A nasal COVID-19 vaccine based on technology licensed from Washington University in St. Louis has been approved for emergency use in India as a booster for people who have already received two doses of other COVID-19 vaccines.

A study involving School of Medicine researchers supports the idea that some T cells that react to microbes also may react to normal human proteins, causing autoimmune disease. The findings promise to accelerate efforts to improve diagnostic tools and treatments for autoimmune diseases.